Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses

Area of Science:

• Cell Biology
• Metabolic Pathways
• Cancer Research

Background:

• p53 is a critical tumor suppressor involved in cell-cycle arrest, senescence, and apoptosis.
• Emerging evidence highlights p53's role in cell metabolism, oxidative stress responses, and ferroptosis.
• The precise mechanisms by which p53 integrates metabolic activities into tumor suppression are not fully understood.

Purpose of the Study:

• To identify novel transcriptional targets of p53.
• To investigate the role of these targets in metabolic regulation and tumor suppression.
• To elucidate the connection between p53, polyamine metabolism, and ferroptosis.

Main Methods:

• Identification of SAT1 as a p53 transcriptional target.
• Analysis of SAT1's role in polyamine catabolism.
• Assessment of SAT1's impact on lipid peroxidation and ferroptosis induction.
• In vivo studies using xenograft tumor models.
• CRISPR-cas9 gene editing to assess SAT1's role in p53-mediated ferroptosis.
• Correlation analysis with ALOX15 expression and inhibitor studies.

Main Results:

• SAT1 (spermidine/spermine N1-acetyltransferase 1) is a direct transcriptional target of p53.
• SAT1 activation induces lipid peroxidation and sensitizes cells to ferroptosis under reactive oxygen species (ROS) stress.
• SAT1 expression suppresses tumor growth in vivo.
• SAT1 is downregulated in human tumors.
• SAT1 knockout partially blocks p53-mediated ferroptosis.
• SAT1-induced ferroptosis is dependent on arachidonate 15-lipoxygenase (ALOX15).

Conclusions:

• SAT1 is a novel metabolic target of p53 that mediates ferroptotic cell death.
• p53 utilizes SAT1 to regulate polyamine metabolism and induce ferroptosis for tumor suppression.
• These findings offer new insights into the interplay between metabolism, ferroptosis, and cancer therapy.